Loading stock research

Invesco CurrencyShares Swedish Krona Trust

FXS

Financial ServicesAMEX

Sign in to save

$94.4897

-$0.4707 (-0.50%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

FXS News

News and disclosures filtered by period, publisher, and event group.

2 / 2

Filter options

Results

Select a headline to open the full news page in the app.

Jun 4, 2026, 9:00 AMgurufocus.comFXS

Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026

Company announcementsFinancial reports

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) today announced that pivotal Phase 2 results from the PROGRESS study evaluating zilurgiser

May 30, 2026, 12:00 PMgurufocus.comFXS

Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026

Company announcements

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data from its rare liver disease programs. Late-breaking result

Loading disclosure news